Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
While conventional approaches for inflammatory bowel diseases mainly focus on
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
[HTML][HTML] Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome, and immune responses in colitis.
Y Lee, K Sugihara, MG Gillilland III, S Jon… - Nature …, 2020 - ncbi.nlm.nih.gov
While conventional approaches for inflammatory bowel diseases (IBD) mainly focus on
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Y Lee, K Sugihara, MG Gillilland, S Jon… - Nature …, 2020 - pure.kaist.ac.kr
While conventional approaches for inflammatory bowel diseases mainly focus on
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Y Lee, K Sugihara, MG Gillilland 3rd… - Nature …, 2020 - pubmed.ncbi.nlm.nih.gov
While conventional approaches for inflammatory bowel diseases mainly focus on
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis.
Y Lee, K Sugihara, MG Gillilland 3rd, S Jon… - Nature …, 2019 - europepmc.org
While conventional approaches for inflammatory bowel diseases (IBD) mainly focus on
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
[引用][C] Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Y Lee, K Sugihara, MG Gillilland, S Jon, N Kamada… - Nature Materials, 2019 - cir.nii.ac.jp
Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal
barrier, microbiome and immune responses in colitis | CiNii Research CiNii 国立情報学研究所 …
barrier, microbiome and immune responses in colitis | CiNii Research CiNii 国立情報学研究所 …
Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Y Lee, K Sugihara, MG Gillilland, S Jon… - Nature …, 2020 - ui.adsabs.harvard.edu
While conventional approaches for inflammatory bowel diseases mainly focus on
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
[PDF][PDF] Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Y Lee, K Sugihara, MGG III, S Jon, N Kamada, JJ Moon - moonlab.engin.umich.edu
While conventional approaches for inflammatory bowel diseases mainly focus on
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Y Lee, K Sugihara, MG Gillilland III, S Jon… - NATURE …, 2020 - koasas.kaist.ac.kr
While conventional approaches for inflammatory bowel diseases mainly focus on
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Y Lee, K Sugihara, MG Gillilland, S Jon… - Nature …, 2020 - pure.ewha.ac.kr
While conventional approaches for inflammatory bowel diseases mainly focus on
suppressing hyperactive immune responses, it remains unclear how to address disrupted …
suppressing hyperactive immune responses, it remains unclear how to address disrupted …